Neuropeptide Y-Induced Orexigenic Action Is Attenuated by the Orexin Receptor Antagonist in Bullfrog Larvae

Frontiers in Neuroscience - Switzerland
doi 10.3389/fnins.2017.00176
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Frontiers Media SA

Related search

Ghrelin, an Endogenous Growth Hormone Secretagogue, Is a Novel Orexigenic Peptide That Antagonizes Leptin Action Through the Activation of Hypothalamic Neuropeptide Y/Y1 Receptor Pathway

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2001English

Peripartum Changes in the Orexigenic CNS Peptide Neuropeptide-Y in Gestational Diabetics

Journal of Diabetes Research and Clinical Metabolism
2013English

Inhibition of Ghrelin-Induced Feeding in Rats by Pretreatment With a Novel Dual Orexin Receptor Antagonist

Journal of Physiological Sciences
Physiology
2017English

In the Amygdala Anxiolytic Action of mGlu5 Receptors Antagonist MPEP Involves Neuropeptide Y but Not GABAA Signaling

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2003English

A Selective Orexin-1 Receptor Antagonist, SB334867, Blocks 2-Dg-Induced Gastric Acid Secretion in Rats

Neuroscience Letters
Neuroscience
2005English

Endothelin-A Receptor Antagonist Mediated Vasodilatation Is Attenuated by Inhibition of Nitric Oxide Synthesis and by Endothelin-B Receptor Blockade

Circulation
Cardiovascular MedicinePhysiologyCardiology
1998English

Neuropeptide Y Is Produced by Adipose Tissue Macrophages and Regulates Obesity-Induced Inflammation

PLoS ONE
Multidisciplinary
2013English

Role of Hypothalamic Neuropeptide Y and Orexigenic Peptides in Anorexia Associated With Experimental Colitis in the Rat

Clinical Science
Medicine
2001English

Antipsychotic-Induced Catalepsy Is Attenuated in Mice Lacking the M4 Muscarinic Acetylcholine Receptor

European Journal of Pharmacology
Pharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy